The Biology of HIV Transmission
Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Aug 30, 2001
Current as of December 03, 2023
Persons with early HIV infection may represent high transmission risk to their partners. Early infection, characterized by rapid virologic replication, insufficient immunologic control of infection, and more rapid course of disease progression, may be associated with increased infectiousness. The viral determinants of transmission may in part be explained by viral burden in blood, genital fluids, and oral cavity fluids. All three fluids may be the source for transmitted virus. Persons with suspected HIV infection are asked to identify their possible source partners. The importance of partn...
- Inclusion Criteria
- Patients may be eligible for this study if they:
- Are at least 18 years old.
- Have sex with or share injection drugs with a person who is thought to have early HIV infection, or if they have recently become HIV-positive.
- Can provide written consent.
- Are available for a follow-up period of at least 4 weeks.
The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
San Diego, California, United States
Los Angeles, California, United States
San Francisco, California, United States
All reviews come from applied patients